Seemingly incurable ulcers were successfully treated at the University of Szeged within the framework of this European Union project. The university, as a consortium member, received support from the EDIOP’s research and development area. The beneficiary of the project was Solvo Biotechnology Ltd., which merged with another subsidiary, Charles River Laboratories Hungary Kft., located in Hungary, in December 2022. They continued the project’s implementation. In this pharmaceutical industry-related, stem cell-based R&D project, the biotechnology company...